Results 101 to 110 of about 316,033 (212)
Background: In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combination with peginterferon and ribavirin (PR) significantly increased sustained virologic response (SVR) rates compared with PR alone.
Bambang Adiwijaya +79 more
core +1 more source
Alpha-fetoprotein in chronic hepatitis C
Ching-Sheng Hsu
doaj +1 more source
Patients with chronic hepatitis B virus (HBV) infection have a substantial risk of reactivation and jaundice following the use of immunosuppressant therapy.
Pol, Stanislas +7 more
core
Background: Sofosbuvir is on the world organization’s list of essential medicines, the most effective and safe medicines needed in health system. It plays a special role in treatment of chronic hepatitis C and offers many advantages due to its high ...
Muhammad Ikhlaq +3 more
doaj
FREQUENCY OF TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
: BACKGROUND: In developing countries, Diabetes Mellitus and Hepatitis C virus infection are major public health problems. A range of extra-hepatic manifestation such as artharlgia, thyroiditis and Type 2 Diabetes Mellitus are associated with Hepatitis C
Sumera Riaz +2 more
doaj
Lifetime medical costs of chronic hepatitis C in the United States. [PDF]
Abimbola TO +4 more
europepmc +1 more source
Health care costs associated with disease progression of untreated chronic hepatitis C in the United States. [PDF]
Jang SC +5 more
europepmc +1 more source
Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C. [PDF]
Lee JW +11 more
europepmc +1 more source
Steatotic liver disease in patients with chronic hepatitis C. [PDF]
Janczura J +6 more
europepmc +1 more source
From Discovery to Cure-Where Are We Now? Mortality Trends in Chronic Hepatitis C: An Analysis of CDC WONDER Database (1999-2023). [PDF]
Ullah A +8 more
europepmc +1 more source

